PRRT2 and amnesia: Although chelerythrine affects all PKC isoforms at high doses [5], (1) ZIP does not affect conventional and novel PKCs [5], and inhibition of these other PKCs does not affect memory retention [2]; and (2) the common target of the two inhibitors is PKMζ, and both agents cause the same pattern of amnesia.